Quarta, G.; Ferrari, P.; Giammarresi, A.; Malanchini, G.; Leidi, C.; Senni, M.; De Filippo, P.
Azygos Vein ICD Lead Implantation Lowers Defibrillation Threshold in a Patient with Hypertrophic Cardiomyopathy. Cardiogenetics 2021, 11, 185-190.
https://doi.org/10.3390/cardiogenetics11040019
AMA Style
Quarta G, Ferrari P, Giammarresi A, Malanchini G, Leidi C, Senni M, De Filippo P.
Azygos Vein ICD Lead Implantation Lowers Defibrillation Threshold in a Patient with Hypertrophic Cardiomyopathy. Cardiogenetics. 2021; 11(4):185-190.
https://doi.org/10.3390/cardiogenetics11040019
Chicago/Turabian Style
Quarta, Giovanni, Paola Ferrari, Andrea Giammarresi, Giovanni Malanchini, Cristina Leidi, Michele Senni, and Paolo De Filippo.
2021. "Azygos Vein ICD Lead Implantation Lowers Defibrillation Threshold in a Patient with Hypertrophic Cardiomyopathy" Cardiogenetics 11, no. 4: 185-190.
https://doi.org/10.3390/cardiogenetics11040019
APA Style
Quarta, G., Ferrari, P., Giammarresi, A., Malanchini, G., Leidi, C., Senni, M., & De Filippo, P.
(2021). Azygos Vein ICD Lead Implantation Lowers Defibrillation Threshold in a Patient with Hypertrophic Cardiomyopathy. Cardiogenetics, 11(4), 185-190.
https://doi.org/10.3390/cardiogenetics11040019